COVID-19: Melatonin as a potential adjuvant treatment.
Identifieur interne : 000897 ( 2020/Analysis ); précédent : 000896; suivant : 000898COVID-19: Melatonin as a potential adjuvant treatment.
Auteurs : Rui Zhang [République populaire de Chine] ; Xuebin Wang [République populaire de Chine] ; Leng Ni [République populaire de Chine] ; Xiao Di [République populaire de Chine] ; Baitao Ma [République populaire de Chine] ; Shuai Niu [République populaire de Chine] ; Changwei Liu [République populaire de Chine] ; Russel J. Reiter [États-Unis]Source :
- Life sciences [ 1879-0631 ] ; 2020.
Abstract
This article summarizes the likely benefits of melatonin in the attenuation of COVID-19 based on its putative pathogenesis. The recent outbreak of COVID-19 has become a pandemic with tens of thousands of infected patients. Based on clinical features, pathology, the pathogenesis of acute respiratory disorder induced by either highly homogenous coronaviruses or other pathogens, the evidence suggests that excessive inflammation, oxidation, and an exaggerated immune response very likely contribute to COVID-19 pathology. This leads to a cytokine storm and subsequent progression to acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) and often death. Melatonin, a well-known anti-inflammatory and anti-oxidative molecule, is protective against ALI/ARDS caused by viral and other pathogens. Melatonin is effective in critical care patients by reducing vessel permeability, anxiety, sedation use, and improving sleeping quality, which might also be beneficial for better clinical outcomes for COVID-19 patients. Notably, melatonin has a high safety profile. There is significant data showing that melatonin limits virus-related diseases and would also likely be beneficial in COVID-19 patients. Additional experiments and clinical studies are required to confirm this speculation.
DOI: 10.1016/j.lfs.2020.117583
PubMed: 32217117
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000501
- to stream PubMed, to step Curation: 000501
- to stream PubMed, to step Checkpoint: 000710
- to stream Ncbi, to step Merge: 003561
- to stream Ncbi, to step Curation: 003561
- to stream Ncbi, to step Checkpoint: 003561
- to stream Main, to step Merge: 000897
- to stream Main, to step Curation: 000897
- to stream Main, to step Exploration: 000897
- to stream 2020, to step Extraction: 000897
Links to Exploration step
pubmed:32217117Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">COVID-19: Melatonin as a potential adjuvant treatment.</title><author><name sortKey="Zhang, Rui" sort="Zhang, Rui" uniqKey="Zhang R" first="Rui" last="Zhang">Rui Zhang</name><affiliation wicri:level="3"><nlm:affiliation>Department of Vascular Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Vascular Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing</wicri:regionArea><placeName><settlement type="city">Pékin</settlement></placeName></affiliation></author><author><name sortKey="Wang, Xuebin" sort="Wang, Xuebin" uniqKey="Wang X" first="Xuebin" last="Wang">Xuebin Wang</name><affiliation wicri:level="3"><nlm:affiliation>Department of Vascular Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Vascular Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing</wicri:regionArea><placeName><settlement type="city">Pékin</settlement></placeName></affiliation></author><author><name sortKey="Ni, Leng" sort="Ni, Leng" uniqKey="Ni L" first="Leng" last="Ni">Leng Ni</name><affiliation wicri:level="3"><nlm:affiliation>Department of Vascular Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Vascular Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing</wicri:regionArea><placeName><settlement type="city">Pékin</settlement></placeName></affiliation></author><author><name sortKey="Di, Xiao" sort="Di, Xiao" uniqKey="Di X" first="Xiao" last="Di">Xiao Di</name><affiliation wicri:level="3"><nlm:affiliation>Department of Vascular Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Vascular Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing</wicri:regionArea><placeName><settlement type="city">Pékin</settlement></placeName></affiliation></author><author><name sortKey="Ma, Baitao" sort="Ma, Baitao" uniqKey="Ma B" first="Baitao" last="Ma">Baitao Ma</name><affiliation wicri:level="3"><nlm:affiliation>Department of Vascular Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Vascular Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing</wicri:regionArea><placeName><settlement type="city">Pékin</settlement></placeName></affiliation></author><author><name sortKey="Niu, Shuai" sort="Niu, Shuai" uniqKey="Niu S" first="Shuai" last="Niu">Shuai Niu</name><affiliation wicri:level="3"><nlm:affiliation>Department of Vascular Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Vascular Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing</wicri:regionArea><placeName><settlement type="city">Pékin</settlement></placeName></affiliation></author><author><name sortKey="Liu, Changwei" sort="Liu, Changwei" uniqKey="Liu C" first="Changwei" last="Liu">Changwei Liu</name><affiliation wicri:level="3"><nlm:affiliation>Department of Vascular Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. Electronic address: liucw@vip.sina.com.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Vascular Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing</wicri:regionArea><placeName><settlement type="city">Pékin</settlement></placeName></affiliation></author><author><name sortKey="Reiter, Russel J" sort="Reiter, Russel J" uniqKey="Reiter R" first="Russel J" last="Reiter">Russel J. Reiter</name><affiliation wicri:level="2"><nlm:affiliation>Department of Cell Systems and Anatomy, UT Health San Antonio, San Antonio, TX 78229, USA. Electronic address: reiter@uthscsa.edu.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Cell Systems and Anatomy, UT Health San Antonio, San Antonio, TX 78229</wicri:regionArea><placeName><region type="state">Texas</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32217117</idno><idno type="pmid">32217117</idno><idno type="doi">10.1016/j.lfs.2020.117583</idno><idno type="wicri:Area/PubMed/Corpus">000501</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000501</idno><idno type="wicri:Area/PubMed/Curation">000501</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000501</idno><idno type="wicri:Area/PubMed/Checkpoint">000710</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000710</idno><idno type="wicri:Area/Ncbi/Merge">003561</idno><idno type="wicri:Area/Ncbi/Curation">003561</idno><idno type="wicri:Area/Ncbi/Checkpoint">003561</idno><idno type="wicri:Area/Main/Merge">000897</idno><idno type="wicri:Area/Main/Curation">000897</idno><idno type="wicri:Area/Main/Exploration">000897</idno><idno type="wicri:Area/2020/Extraction">000897</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">COVID-19: Melatonin as a potential adjuvant treatment.</title><author><name sortKey="Zhang, Rui" sort="Zhang, Rui" uniqKey="Zhang R" first="Rui" last="Zhang">Rui Zhang</name><affiliation wicri:level="3"><nlm:affiliation>Department of Vascular Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Vascular Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing</wicri:regionArea><placeName><settlement type="city">Pékin</settlement></placeName></affiliation></author><author><name sortKey="Wang, Xuebin" sort="Wang, Xuebin" uniqKey="Wang X" first="Xuebin" last="Wang">Xuebin Wang</name><affiliation wicri:level="3"><nlm:affiliation>Department of Vascular Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Vascular Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing</wicri:regionArea><placeName><settlement type="city">Pékin</settlement></placeName></affiliation></author><author><name sortKey="Ni, Leng" sort="Ni, Leng" uniqKey="Ni L" first="Leng" last="Ni">Leng Ni</name><affiliation wicri:level="3"><nlm:affiliation>Department of Vascular Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Vascular Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing</wicri:regionArea><placeName><settlement type="city">Pékin</settlement></placeName></affiliation></author><author><name sortKey="Di, Xiao" sort="Di, Xiao" uniqKey="Di X" first="Xiao" last="Di">Xiao Di</name><affiliation wicri:level="3"><nlm:affiliation>Department of Vascular Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Vascular Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing</wicri:regionArea><placeName><settlement type="city">Pékin</settlement></placeName></affiliation></author><author><name sortKey="Ma, Baitao" sort="Ma, Baitao" uniqKey="Ma B" first="Baitao" last="Ma">Baitao Ma</name><affiliation wicri:level="3"><nlm:affiliation>Department of Vascular Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Vascular Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing</wicri:regionArea><placeName><settlement type="city">Pékin</settlement></placeName></affiliation></author><author><name sortKey="Niu, Shuai" sort="Niu, Shuai" uniqKey="Niu S" first="Shuai" last="Niu">Shuai Niu</name><affiliation wicri:level="3"><nlm:affiliation>Department of Vascular Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Vascular Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing</wicri:regionArea><placeName><settlement type="city">Pékin</settlement></placeName></affiliation></author><author><name sortKey="Liu, Changwei" sort="Liu, Changwei" uniqKey="Liu C" first="Changwei" last="Liu">Changwei Liu</name><affiliation wicri:level="3"><nlm:affiliation>Department of Vascular Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. Electronic address: liucw@vip.sina.com.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Vascular Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing</wicri:regionArea><placeName><settlement type="city">Pékin</settlement></placeName></affiliation></author><author><name sortKey="Reiter, Russel J" sort="Reiter, Russel J" uniqKey="Reiter R" first="Russel J" last="Reiter">Russel J. Reiter</name><affiliation wicri:level="2"><nlm:affiliation>Department of Cell Systems and Anatomy, UT Health San Antonio, San Antonio, TX 78229, USA. Electronic address: reiter@uthscsa.edu.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Cell Systems and Anatomy, UT Health San Antonio, San Antonio, TX 78229</wicri:regionArea><placeName><region type="state">Texas</region></placeName></affiliation></author></analytic><series><title level="j">Life sciences</title><idno type="eISSN">1879-0631</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">This article summarizes the likely benefits of melatonin in the attenuation of COVID-19 based on its putative pathogenesis. The recent outbreak of COVID-19 has become a pandemic with tens of thousands of infected patients. Based on clinical features, pathology, the pathogenesis of acute respiratory disorder induced by either highly homogenous coronaviruses or other pathogens, the evidence suggests that excessive inflammation, oxidation, and an exaggerated immune response very likely contribute to COVID-19 pathology. This leads to a cytokine storm and subsequent progression to acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) and often death. Melatonin, a well-known anti-inflammatory and anti-oxidative molecule, is protective against ALI/ARDS caused by viral and other pathogens. Melatonin is effective in critical care patients by reducing vessel permeability, anxiety, sedation use, and improving sleeping quality, which might also be beneficial for better clinical outcomes for COVID-19 patients. Notably, melatonin has a high safety profile. There is significant data showing that melatonin limits virus-related diseases and would also likely be beneficial in COVID-19 patients. Additional experiments and clinical studies are required to confirm this speculation.</div></front></TEI><affiliations><list><country><li>République populaire de Chine</li><li>États-Unis</li></country><region><li>Texas</li></region><settlement><li>Pékin</li></settlement></list><tree><country name="République populaire de Chine"><noRegion><name sortKey="Zhang, Rui" sort="Zhang, Rui" uniqKey="Zhang R" first="Rui" last="Zhang">Rui Zhang</name></noRegion><name sortKey="Di, Xiao" sort="Di, Xiao" uniqKey="Di X" first="Xiao" last="Di">Xiao Di</name><name sortKey="Liu, Changwei" sort="Liu, Changwei" uniqKey="Liu C" first="Changwei" last="Liu">Changwei Liu</name><name sortKey="Ma, Baitao" sort="Ma, Baitao" uniqKey="Ma B" first="Baitao" last="Ma">Baitao Ma</name><name sortKey="Ni, Leng" sort="Ni, Leng" uniqKey="Ni L" first="Leng" last="Ni">Leng Ni</name><name sortKey="Niu, Shuai" sort="Niu, Shuai" uniqKey="Niu S" first="Shuai" last="Niu">Shuai Niu</name><name sortKey="Wang, Xuebin" sort="Wang, Xuebin" uniqKey="Wang X" first="Xuebin" last="Wang">Xuebin Wang</name></country><country name="États-Unis"><region name="Texas"><name sortKey="Reiter, Russel J" sort="Reiter, Russel J" uniqKey="Reiter R" first="Russel J" last="Reiter">Russel J. Reiter</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/2020/Analysis
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000897 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd -nk 000897 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SrasV1
|flux= 2020
|étape= Analysis
|type= RBID
|clé= pubmed:32217117
|texte= COVID-19: Melatonin as a potential adjuvant treatment.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/RBID.i -Sk "pubmed:32217117" \
| HfdSelect -Kh $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd \
| NlmPubMed2Wicri -a SrasV1
| This area was generated with Dilib version V0.6.33. |  |